| Date Filed | Type | Description |
| 06/16/2023 |
4
| Berrey M Michelle (President, R&D & CMO) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 1,246 shares
@ $12.04, valued at
$15k
|
|
| 03/16/2023 |
4
| Berrey M Michelle (President, R&D & CMO) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 1,246 shares
@ $15.79, valued at
$19.7k
|
|
| 01/31/2023 |
4
| Berrey M Michelle (President, R&D & CMO) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Granted 14,700 shares
@ $0
Granted 24,000 options to buy
@ $18.4, valued at
$441.6k
|
|
| 01/03/2023 |
4
| Berrey M Michelle (President, R&D & CMO) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 765 shares
@ $12.37, valued at
$9.5k
|
|
| 12/16/2022 |
4
| Berrey M Michelle (President, R&D and CMO) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 1,246 shares
@ $14.94, valued at
$18.6k
|
|
| 09/16/2022 |
4
| Berrey M Michelle (President, R&D and CMO) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 1,246 shares
@ $17.14, valued at
$21.4k
|
|
| 06/16/2022 |
4
| Berrey M Michelle (President, R&D and CMO) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 4,984 shares
@ $12.1, valued at
$60.3k
|
|
| 01/31/2022 |
4
| Berrey M Michelle (President, R&D and CMO) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Granted 10,300 shares
@ $0
Granted 17,600 options to buy
@ $14.44, valued at
$254.1k
|
|
| 06/15/2021 |
4
| Berrey M Michelle (President, R&D and CMO) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Granted 67,118 shares
@ $0
Granted 93,000 options to buy
@ $21.38, valued at
$2M
|
|
| 06/15/2021 |
3
| Berrey M Michelle (President, R&D and CMO) has filed a Form 3 on INTERCEPT PHARMACEUTICALS, INC. |
| 01/25/2019 |
4
| Berrey M Michelle (President and CEO) has filed a Form 4 on CHIMERIX INC|
Txns:
| Granted 400,000 options to buy
@ $2.41, valued at
$964k
|
|
| 06/14/2018 |
4
| Berrey M Michelle (President and CEO) has filed a Form 4 on CHIMERIX INC|
Txns:
| Bought 10,000 shares
@ $4.5015, valued at
$45k
|
|
| 05/10/2018 |
4
| Berrey M Michelle (President and CEO) has filed a Form 4 on CHIMERIX INC|
Txns:
| Exercised 11,250 options to buy
@ $4.26, valued at
$47.9k
|
|
| 03/08/2018 |
4
| Berrey M Michelle (President and CEO) has filed a Form 4 on CHIMERIX INC|
Txns:
| Exercised 10,071 options to buy
@ $4.26, valued at
$42.9k
|
|
| 01/29/2018 |
4
| Berrey M Michelle (President and CEO) has filed a Form 4 on CHIMERIX INC|
Txns:
| Granted 400,000 options to buy
@ $4.68, valued at
$1.9M
|
|
| 06/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/31/2017 |
4
| Berrey M Michelle (President and CEO) has filed a Form 4 on CHIMERIX INC|
Txns:
| Granted 4,523 shares
@ $4.097, valued at
$18.5k
|
|
| 01/26/2017 |
4
| Berrey M Michelle (President and CEO) has filed a Form 4 on CHIMERIX INC|
Txns:
| Granted 74,000 shares
@ $0
Granted 148,000 options to buy
@ $5.14, valued at
$760.7k
|
|
| 12/01/2016 |
4
| Berrey M Michelle (President and CEO) has filed a Form 4 on CHIMERIX INC|
Txns:
| Exercised 2,400 options to buy
@ $4.26, valued at
$10.2k
|
|
| 09/19/2016 |
4
| Berrey M Michelle (President and CEO) has filed a Form 4 on CHIMERIX INC|
Txns:
| Granted 4,523 shares
@ $4.05, valued at
$18.3k
|
|
| 08/31/2016 |
4
| Berrey M Michelle (President and CEO) has filed a Form 4 on CHIMERIX INC|
Txns:
| Bought 22,417 shares
@ $4.471, valued at
$100.2k
|
|
| 06/28/2016 |
4
| Berrey M Michelle (President and CEO) has filed a Form 4 on CHIMERIX INC |
| 05/11/2016 |
4
| Berrey M Michelle (President and CEO) has filed a Form 4 on CHIMERIX INC |
| 03/03/2016 |
4
| Berrey M Michelle (President and CEO) has filed a Form 4 on CHIMERIX INC |
| 08/26/2013 |
4
| Berrey M Michelle (Chief Medical Officer) has filed a Form 4 on CHIMERIX INC|
Txns:
| Bought 5,540 shares
@ $18.7, valued at
$103.6k
|
|
| 01/17/2012 |
4
| Berrey M Michelle (Chief Medical Officer) has filed a Form 4 on Pharmasset Inc|
Txns:
| Disposed/sold 98,217 options to buy
@ $2.1, valued at
$206.3k
Disposed/sold 9,376 options to buy
@ $9.3, valued at
$87.2k
Disposed/sold 25,000 options to buy
@ $10.83, valued at
$270.8k
Disposed/sold 59,000 options to buy
@ $16.17, valued at
$954k
Disposed/sold 75,000 options to buy
@ $83.52, valued at
$6.3M
|
|
| 12/05/2011 |
4
| Berrey M Michelle (Chief Medical Officer) has filed a Form 4 on Pharmasset Inc|
Txns:
| Sold 3,126 shares
@ $130.33, valued at
$407.4k
Exercised 3,126 options to buy
@ $6.835, valued at
$21.4k
Exercised 3,126 options to buy
@ $10.825, valued at
$33.8k
|
|
| 11/03/2011 |
4
| Berrey M Michelle (Chief Medical Officer) has filed a Form 4 on Pharmasset Inc|
Txns:
| Sold 3,124 shares
@ $74.56, valued at
$232.9k
Exercised 3,124 options to buy
@ $6.835, valued at
$21.4k
|
|
| 10/13/2011 |
4
| Berrey M Michelle (Chief Medical Officer) has filed a Form 4 on Pharmasset Inc|
Txns:
| Granted 75,000 options to buy
@ $83.52, valued at
$6.3M
|
|
| 09/06/2011 |
4
| Berrey M Michelle (Chief Medical Officer) has filed a Form 4 on Pharmasset Inc|
Txns:
| Sold 3,124 shares
@ $65.6258, valued at
$205k
Exercised 3,124 options to buy
@ $10.825, valued at
$33.8k
|
|
| 07/05/2011 |
4
| Berrey M Michelle (Chief Medical Officer) has filed a Form 4 on Pharmasset Inc|
Txns:
| Sold 938 shares
@ $111.83, valued at
$104.9k
Exercised 938 options to buy
@ $18.6, valued at
$17.4k
|
|
| 10/18/2010 |
4
| Berrey M Michelle (Chief Medical Officer) has filed a Form 4 on Pharmasset Inc|
Txns:
| Granted 29,500 options to buy
@ $32.33, valued at
$953.7k
|
|
| 06/18/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/26/2009 |
4
| Berrey M Michelle (Chief Medical Officer) has filed a Form 4 on Pharmasset Inc |